217 related articles for article (PubMed ID: 14765798)
1. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
Boria PA; Murry DJ; Bennett PF; Glickman NW; Snyder PW; Merkel BL; Schlittler DL; Mutsaers AJ; Thomas RM; Knapp DW
J Am Vet Med Assoc; 2004 Feb; 224(3):388-94. PubMed ID: 14765798
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs.
Schmidt BR; Glickman NW; DeNicola DB; de Gortari AE; Knapp DW
J Am Vet Med Assoc; 2001 Jun; 218(11):1783-6. PubMed ID: 11394830
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs.
Mutsaers AJ; Glickman NW; DeNicola DB; Widmer WR; Bonney PL; Hahn KA; Knapp DW
J Am Vet Med Assoc; 2002 Jun; 220(12):1813-7. PubMed ID: 12092954
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
[TBL] [Abstract][Full Text] [Related]
5. Intralesional implant for treatment of primary oral malignant melanoma in dogs.
Kitchell BE; Brown DM; Luck EE; Woods LL; Orenberg EK; Bloch DA
J Am Vet Med Assoc; 1994 Jan; 204(2):229-36. PubMed ID: 8144382
[TBL] [Abstract][Full Text] [Related]
6. Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
Henry CJ; Flesner BK; Bechtel SA; Bryan JN; Tate DJ; Selting KA; Lattimer JC; Bryan ME; Grubb L; Hausheer F
J Vet Intern Med; 2018 Jan; 32(1):370-376. PubMed ID: 29080252
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose cyclophosphamide with piroxicam on tumour neovascularization in a canine oral malignant melanoma-xenografted mouse model.
Choisunirachon N; Jaroensong T; Yoshida K; Saeki K; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
Vet Comp Oncol; 2015 Dec; 13(4):424-32. PubMed ID: 23890026
[TBL] [Abstract][Full Text] [Related]
8. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
de Vos J; Ramos Vega S; Noorman E; de Vos P
Vet Comp Oncol; 2012 Sep; 10(3):206-13. PubMed ID: 22236048
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer.
Knapp DW; Glickman NW; Widmer WR; DeNicola DB; Adams LG; Kuczek T; Bonney PL; DeGortari AE; Han C; Glickman LT
Cancer Chemother Pharmacol; 2000; 46(3):221-6. PubMed ID: 11021739
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells.
Knapp DW; Chan TC; Kuczek T; Reagan WJ; Park B
Am J Vet Res; 1995 Jun; 56(6):801-5. PubMed ID: 7653891
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors.
Knapp DW; Richardson RC; Bottoms GD; Teclaw R; Chan TC
Cancer Chemother Pharmacol; 1992; 29(3):214-8. PubMed ID: 1733554
[TBL] [Abstract][Full Text] [Related]
12. Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
Mohammed SI; Craig BA; Mutsaers AJ; Glickman NW; Snyder PW; deGortari AE; Schlittler DL; Coffman KT; Bonney PL; Knapp DW
Mol Cancer Ther; 2003 Feb; 2(2):183-8. PubMed ID: 12589035
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma.
Upton ML; Tangner CH; Payton ME
J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
Brockley LK; Cooper MA; Bennett PF
N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL
J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923
[TBL] [Abstract][Full Text] [Related]
16. Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study.
Chon E; McCartan L; Kubicek LN; Vail DM
Vet Comp Oncol; 2012 Sep; 10(3):184-93. PubMed ID: 22235941
[TBL] [Abstract][Full Text] [Related]
17. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987-1997).
Freeman KP; Hahn KA; Harris FD; King GK
J Vet Intern Med; 2003; 17(1):96-101. PubMed ID: 12564733
[TBL] [Abstract][Full Text] [Related]
18. Treatment of eight dogs with nasal tumours with alternating doses of doxorubicin and carboplatin in conjunction with oral piroxicam.
Langova V; Mutsaers AJ; Phillips B; Straw R
Aust Vet J; 2004 Nov; 82(11):676-80. PubMed ID: 15977611
[TBL] [Abstract][Full Text] [Related]
19. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
[TBL] [Abstract][Full Text] [Related]
20. Histologic evaluation of mandibular and medial retropharyngeal lymph nodes during staging of oral malignant melanoma and squamous cell carcinoma in dogs.
Grimes JA; Mestrinho LA; Berg J; Cass S; Oblak ML; Murphy S; Amsellem PM; Brown P; Hamaide A; Matz BM
J Am Vet Med Assoc; 2019 Apr; 254(8):938-943. PubMed ID: 30938614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]